Biomotion Sciences Warrant
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for … Read more
Market Cap & Net Worth: Biomotion Sciences Warrant (SLXNW)
Biomotion Sciences Warrant (NASDAQ:SLXNW) has a market capitalization of $154.80 ($154.80) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #42238 globally and #13686 in its home market, demonstrating a -49.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biomotion Sciences Warrant's stock price $0.02 by its total outstanding shares 9106 (9.11K).
Biomotion Sciences Warrant Market Cap History: 2021 to 2026
Biomotion Sciences Warrant's market capitalization history from 2021 to 2026. Data shows change from $5.10K to $154.80 (-52.48% CAGR).
Biomotion Sciences Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biomotion Sciences Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLXNW by Market Capitalization
Companies near Biomotion Sciences Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Biomotion Sciences Warrant by market ranking:
- FRIWO (CEA.SG) (STU:CEA): Ranked #42229 globally with a market cap of $51.13K USD ( €49.81K EUR).
- AOL (WAR:AOL): Ranked #42230 globally with a market cap of $51.13K USD ( zł212.59K PLN).
- Truen Co. Ltd. (KO:417790): Ranked #42239 globally with a market cap of $50.91K USD ( ₩74.55 Million KRW).
- Solidwizard Technology Co., Ltd. (TWO:8416): Ranked #42240 globally with a market cap of $50.91K USD ( NT$1.68 Million TWD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42229 | FRIWO (CEA.SG) | STU:CEA | $51.13K | €5.25 |
| #42230 | AOL | WAR:AOL | $51.13K | zł23.40 |
| #42239 | Truen Co. Ltd. | KO:417790 | $50.91K | ₩7650.00 |
| #42240 | Solidwizard Technology Co., Ltd. | TWO:8416 | $50.91K | NT$168.50 |
Biomotion Sciences Warrant Historical Marketcap From 2021 to 2026
Between 2021 and today, Biomotion Sciences Warrant's market cap moved from $5.10K to $ 154.80, with a yearly change of -52.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $154.80 | -34.62% |
| 2025 | $236.76 | -23.30% |
| 2024 | $308.69 | +20.21% |
| 2023 | $256.79 | -73.40% |
| 2022 | $965.24 | -81.07% |
| 2021 | $5.10K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Biomotion Sciences Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.80 USD |
| MoneyControl | $154.80 USD |
| MarketWatch | $154.80 USD |
| marketcap.company | $154.80 USD |
| Reuters | $154.80 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.